Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 10,053,000 | 10,415,000 | 10,829,000 | 9,045,000 | 8,886,000 |
| Cost of Goods | 2,880,000 | 3,476,000 | 3,238,000 | 2,857,000 | 2,684,000 |
| Gross Profit | 7,173,000 | 6,939,000 | 7,591,000 | 6,188,000 | 6,202,000 |
| Operating Expenses | 4,582,000 | 5,121,000 | 4,384,000 | 4,318,000 | 3,950,000 |
| Operating Income | 2,591,000 | 1,818,000 | 3,207,000 | 1,870,000 | 2,252,000 |
| Interest Expense | 88,000 | 127,000 | 87,000 | 112,000 | 99,000 |
| Other Income | -184,000 | -302,000 | -163,000 | -279,000 | -180,000 |
| Pre-tax Income | 2,319,000 | 1,389,000 | 2,957,000 | 1,479,000 | 1,973,000 |
| Income Tax | 332,000 | 267,000 | 609,000 | 278,000 | 404,000 |
| Net Income Continuous | 2,017,000 | 1,140,000 | 2,343,000 | 1,218,000 | 1,578,000 |
| Minority Interests | -8,000 | -10,000 | -26,000 | -8,000 | -12,000 |
| Net Income | $2,009,000 | $1,130,000 | $2,317,000 | $1,210,000 | $1,566,000 |
| EPS Basic Total Ops | 1.61 | 0.90 | 1.85 | 0.97 | 1.25 |
| EPS Basic Continuous Ops | 1.61 | 0.90 | 1.85 | 0.97 | 1.25 |
| EPS Diluted Total Ops | 1.61 | 0.90 | 1.85 | 0.97 | 1.25 |
| EPS Diluted Continuous Ops | 1.61 | 0.90 | 1.85 | 0.97 | 1.25 |
| EBITDA(a) | $2,856,000 | $1,936,000 | $3,429,000 | $1,977,000 | $2,461,000 |